CN1480163A - Medication of Chinese traditional medicine for treating ischemia in blood vessel of heart and brain - Google Patents
Medication of Chinese traditional medicine for treating ischemia in blood vessel of heart and brain Download PDFInfo
- Publication number
- CN1480163A CN1480163A CNA021323917A CN02132391A CN1480163A CN 1480163 A CN1480163 A CN 1480163A CN A021323917 A CNA021323917 A CN A021323917A CN 02132391 A CN02132391 A CN 02132391A CN 1480163 A CN1480163 A CN 1480163A
- Authority
- CN
- China
- Prior art keywords
- kilograms
- brain
- chinese medicine
- medication
- heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating cardiovascular and cerebrovascular ischemia, such as coronary insufficiency, angina pectoris, myocardial infarction, cerebral thrombus, etc is prepared from theapolyphenol, extract of ginkgo leaf, and 7 Chinese-medicinal materials including astragalus root, liquorice root, dried ginger, etc.
Description
Affiliated technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of human body diseases, particularly a kind of Chinese medicine preparation of preventing and treating cardiovascular and cerebrovascular disease.
Background technology
At present, aspect the preventing and treating of cardiovascular and cerebrovascular vessel ischemic diseases, such two class medicines are arranged.One of its medicine; the active component tea polyphenols pharmaceutical preparation of extracting in the Folium Camelliae sinensis is arranged; be characterized in; tea polyphenols has excellent antioxygenic property and the significant human body oxygen-derived free radicals ability of removing; has the microcirculation in human body of improvement; blood fat reducing, blood sugar lowering, blood pressure lowering, atherosclerosis; antitumor, mutation, antibiotic; radioprotective; defying age stops lipid peroxidation, the liver protecting; anti-allergic effects accompanies diseases such as high celloglobulin disease and atherosclerosis to have preventive and therapeutic effect to the cardiovascular and cerebrovascular vessel ischemic diseases.Two of its medicine, Folium Ginkgo extract pharmaceutical preparation is arranged, be characterized in, Semen Ginkgo is the distinctive medicinal plants of China, Folium Ginkgo extract has following main effect: 1, coronary artery dilator, brain and peripheral vessel, blood flow increasing, improve the nutrition and the oxygen supply of ishemic part, 2, blood viscosity lowering increases erythrocyte deformability, microcirculation improvement, 3, platelet aggregation can efficiently be prevented, thrombus, 4, remove oxygen-derived free radicals, suppress the peroxidating of cell membrane lipid, 5, brain blood circulation and brain cell metabolism there are improvement and facilitation preferably.It is used for the treatment of coronary blood supply insufficiency due to arteriosclerosis and the hypertension, angina pectoris, myocardial infarction, cerebral embolism, the bad illness that causes of cerebral vasospasm and arteries blood supply.
But said medicine also has deficiency, and promptly according to Chinese medical theory and practice, two class medicines are the folk prescription medicine, and its therapeutical effect has certain limitation.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine preparation of making by prescription drug of resisting cardiovascular ischemia, have the complementary action of tea polyphenols and Folium Ginkgo extract, have simultaneously and strengthen and adjust the effect of energy and blood of human body function, reach basic preventive and therapeutic effect disease.
Technical scheme of the present invention is as follows: the composition of the prescription drug that the present invention adopts and the ratio of shared weight thereof are: tea polyphenols is 0.25 kilogram in per 48.05 kilograms of prescription drugs, 25 kilograms of Folium Ginkgos, 13.5 kilograms of the Radixs Astragali, 1.5 kilograms of Radix Astragali decoction pieces, 1.8 kilograms of Fructus Ligustri Lucidi, 1.8 kilograms of Herba Ecliptaes, 0.9 kilogram of Ramulus Cinnamomi, 1.8 kilograms in Radix Glycyrrhizae, 0.5 kilogram of Rhizoma Zingiberis, 1.0 kilograms in Fructus Jujubae.
Said medicine is processed as finished product preparation with the conventional processing and fabricating method of Chinese medicine can take.
Advantage of the present invention is that by the action compensating of tea polyphenols and Folium Ginkgo extract in the above-mentioned prescription, and ancillary drug has significantly improved therapeutic effect to the conditioning enhancing of energy and blood of human body function in the above-mentioned prescription, plays the radical cure effect.Simultaneously, production cost of the present invention is low, and medicine is taken and had no side effect.
Embodiment of the present invention
Weight composition by above-mentioned prescription drug is got raw material ready, it is stand-by that Folium Ginkgo is made Folium Ginkgo extract through abstraction technique, the Radix Astragali, Fructus Ligustri Lucidi, Herba Ecliptae, Ramulus Cinnamomi, Rhizoma Zingiberis, Radix Glycyrrhizae, Fructus Jujubae raw material mixed after the fried technology of Chinese medicine to make the herb liquid of debita spissitudo stand-by, mix with tea polyphenols, Folium Ginkgo extract after Radix Astragali decoction pieces is made as powder, mix with herb liquid again and stir the back and being made as 0.27 with Chinese medicine film-making agent technology and restraining oral.Instructions of taking: three times on the one, each 4-5 sheet.
The curative effect of medicine of the present invention aspect treatment apoplexy (apoplexy) disease, through clinical use with use medicine " SHANHAI PILL " curative effect of [production of Xi'an Hong Qing pharmaceutical factory] contrasts, the result is as follows:
1, use medicine of the present invention to treat 33 examples:
Basic 20 examples of curing account for 62.5% of total case, and progressive 11 examples account for 35.2% of total case, and invalid 1 example accounts for 3.1% of total case, worsens 0 example.Total effective rate is 96.9%.
2, use the medicine SHANHAI PILL to treat 30 examples:
Basic 10 examples of curing account for 33.3% of total case, and progressive 15 examples account for 50.0% of total case, and invalid 3 examples account for 10.0% of total case, worsen 2 examples, account for 6.7% of total case.Total effective rate is 83.3%.
Claims (2)
1, a kind of Chinese medicine preparation of resisting cardiovascular ischemia, made by prescription drug, it is characterized in that: the composition of the prescription drug of said preparation and weight ratio thereof are: tea polyphenols is 0.25 kilogram in per 48.05 kilograms of prescription drugs, and Folium Ginkgo is 25 kilograms, the Radix Astragali is 13.5 kilograms, Radix Astragali decoction pieces is 1.5 kilograms, and Fructus Ligustri Lucidi is 1.8 kilograms, and Herba Ecliptae is 1.8 kilograms, Ramulus Cinnamomi is 0.9 kilogram, Radix Glycyrrhizae is 1.8 kilograms, and Rhizoma Zingiberis is 0.5 kilogram, and Fructus Jujubae is 1.0 kilograms.
2, the Chinese medicine preparation of resisting cardiovascular ischemia according to claim 1 is characterized in that: described preparation is a tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02132391 CN1261155C (en) | 2002-09-03 | 2002-09-03 | Medication of Chinese traditional medicine for treating ischemia in blood vessel of heart and brain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02132391 CN1261155C (en) | 2002-09-03 | 2002-09-03 | Medication of Chinese traditional medicine for treating ischemia in blood vessel of heart and brain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1480163A true CN1480163A (en) | 2004-03-10 |
| CN1261155C CN1261155C (en) | 2006-06-28 |
Family
ID=34145174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02132391 Expired - Fee Related CN1261155C (en) | 2002-09-03 | 2002-09-03 | Medication of Chinese traditional medicine for treating ischemia in blood vessel of heart and brain |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1261155C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953917A (en) * | 2010-10-13 | 2011-01-26 | 江中银 | Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof |
-
2002
- 2002-09-03 CN CN 02132391 patent/CN1261155C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953917A (en) * | 2010-10-13 | 2011-01-26 | 江中银 | Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1261155C (en) | 2006-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101274042A (en) | Medicament composition for curing hyperlipemia and method of preparing the same | |
| CN103341052A (en) | Medicine for preventing and treating hypertension, hyperlipidemia, hyperglycemia and hypotension and preparation method thereof | |
| CN102488840B (en) | Blood sugar reducing preparation and preparation method thereof | |
| CN101062339A (en) | Medicine for treating diabetes | |
| CN102302673B (en) | Traditional Chinese medicine compound preparation for preventing and treating diabetic nephropathy (DN) | |
| CN100382840C (en) | Medicine for treating cerebrovascular accident induced by high blood fat | |
| CN103479691A (en) | Lipid-decreasing liver protection traditional Chinese medicine composition | |
| CN1199664C (en) | Chinese medicine for treating cardiovascular and cerebrovascular diseases and its preparing process | |
| CN106310023A (en) | Drug for treating small cell lung cancer, and preparation method and application thereof | |
| CN103027978A (en) | Medicine composition for treating traumatic injury and preparation method of medicine composition | |
| CN1261155C (en) | Medication of Chinese traditional medicine for treating ischemia in blood vessel of heart and brain | |
| CN1058615C (en) | Compound notoginseng preparation | |
| CN105999058B (en) | Bidens bipinnata lipid-lowering tablet | |
| CN101480472B (en) | Medicament for reducing blood pressure and regulating blood fat and production method | |
| CN101293081A (en) | Medicament for treating hyperlipemia and preparation method thereof | |
| CN109172608B (en) | A kind of Chinese medicine composition that can improve sleep quality | |
| CN101129853A (en) | Beverage for clearing lung-heat and relieving cough | |
| CN101549057A (en) | Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same | |
| CN110339293A (en) | A kind of arteries and veins gel resin capsule formula and preparation process | |
| CN102266540B (en) | Chinese medicament for treating constipation | |
| WO2004052382A1 (en) | A kind of chinese traditional medicine having efficacy of reducing blood-fat | |
| CN1650980A (en) | Preparation of medicine using formula containing angelicae sinensis radix etc. for treating gynecopathy algomenorrhea | |
| CN101129997A (en) | Radix curcumae oral liquid for relieving exterior syndrome | |
| CN106177578A (en) | A kind of Chinese medicine composition of blood fat reducing and preparation method thereof | |
| CN101919983A (en) | Chinese materia medica preparation for treating gastritis chronic cholecystitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |